Related Experiment Video
Updated: Feb 18, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
FDA-Required Tobacco Product Inserts & Onserts–and the First Amendment
Graphic health warnings on cigarettes were struck down by courts. Tobacco product inserts and onserts offer a viable alternative for delivering health information and supporting smoking cessation, navigating First Amendment challenges.
Area of Science:
- Public Health Law
- Commercial Speech Doctrine
- Tobacco Control Policy
Background:
- A 2012 federal court ruling invalidated the Food and Drug Administration's (FDA) graphic health warning mandate for cigarettes, citing First Amendment commercial speech protections.
- Tobacco product inserts and onserts present an alternative communication channel for health information, potentially circumventing commercial speech limitations.
- Effective tobacco control strategies require exploring legally sound methods to inform consumers and promote cessation.
Purpose of the Study:
- To examine the Food and Drug Administration's (FDA) legal authority to mandate tobacco product inserts and onserts.
- To demonstrate how the FDA can design and implement inserts/onserts to comply with First Amendment requirements.
- To provide guidance on interpreting the Tobacco Control Act for effective health messaging on tobacco products.
Main Methods:
- Analysis of First Amendment case law concerning compelled commercial speech.
- Examination of the Tobacco Control Act's provisions and objectives.
- Legal and policy analysis of FDA's regulatory authority regarding tobacco product communications.
Main Results:
- Tobacco product inserts and onserts are legally distinguishable from direct product labeling, offering a pathway to convey extensive health information.
- The FDA possesses the authority to require inserts and onserts that effectively support smoking cessation and deliver health warnings.
- Strategic design and implementation can mitigate First Amendment concerns associated with compelled commercial speech.
Conclusions:
- Tobacco product inserts and onserts represent a promising, legally viable strategy for the FDA to enhance tobacco user information and promote public health.
- The findings offer a framework for government agencies seeking to implement compelled disclosures or messaging on commercial products within legal boundaries.
- This approach supports the broader goals of the Tobacco Control Act by enabling more comprehensive health communication to tobacco users.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Products: Biologics, Biosimilars and Interchangeables
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Bioequivalence studies: Biowaivers